serca2a aav1 (Celladon Inc)
Structured Review

Serca2a Aav1, supplied by Celladon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav1%2Eserca2a/aav1+serca2a/pmc08518903-384-7-0
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases"
Article Title: Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases
Journal: Molecular Neurobiology
doi: 10.1007/s12035-021-02555-y
Figure Legend Snippet: Gene therapy approaches in various neurological disorders
Techniques Used: Transgenic Assay, Mouse Assay, Over Expression, Inhibition, Activity Assay, Migration, Expressing, Functional Assay, Activation Assay, Plasmid Preparation, Injection, Recombinant, shRNA, CRISPR
Related Articles
other:Article Title: Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure Article Snippet: R.J.H. is the scientific cofounder of Article Title: The Role of SUMO-1 in Cardiac Oxidative Stress and Hypertrophy Article Snippet: Article Title: Gene Therapy for the Treatment of CPVT Article Snippet: Conflict of Interest Disclosures: RJH is the scientific co-founder of Article Title: Effect of Bortezomib on the Efficacy of AAV9.SERCA2a Treatment to Preserve Cardiac Function in a Rat Pressure-Overload Model of Heart Failure Article Snippet: Conflict of Article Title: High-dose chloroquine is metabolically cardiotoxic by inducing lysosomes and mitochondria dysfunction in a rat model of pressure overload hypertrophy Article Snippet: Article Title: Synergistic Role of Protein Phosphatase Inhibitor 1 and SERCA2a in the Acquisition of the Contractile Phenotype of Arterial Smooth Muscle Cells Article Snippet: Journal Article Title: Adeno-associated virus-mediated gene therapy in cardiovascular disease Article Snippet: Conflicts of Article Title: Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure. Article Snippet: Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests: R.J.H. is the scientific cofounder of |
